Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2021-12, Vol.138 (22), p.2290-2293
Hauptverfasser:	Puzzolo, Maria Cristina, Radice, Giulia, Peragine, Nadia, de Propris, Maria Stefania, Mariglia, Paola, Vignetti, Marco, Vitale, Antonella, Bassan, Renato, Annunziata, Mario, Gaidano, Gianluca, Rambaldi, Alessandro, Chiaretti, Sabina, Guarini, Anna, Foà, Robin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Bispecific - therapeutic use Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Dasatinib - therapeutic use Humans Immune System - drug effects Immune System - immunology Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology Protein Kinase Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!